Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$55,465,523
+$1,313,753 QoQ
Shares Held
218,394
-1.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
2.12%
of 13F equity value
Holder Rank
#418
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KLINGENSTEIN FIELDS & CO LP holds $198,349,712 across 10 Drug Manufacturers - General names. JNJ ranks #2 (28.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
91,363 | $109,583,531 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
218,394 | $55,465,523 | |
| 3 | MRK |
Merck & Co., Inc.
|
223,496 | $28,719,236 | |
| 4 | ABBV |
AbbVie Inc.
|
5,534 | $1,392,575 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
8,138 | $1,028,154 | |
| 6 | BIIB |
Biogen Inc.
|
2,731 | $590,059 | |
| 7 | NVS |
Novartis AG
|
3,047 | $477,525 | |
| 8 | NVO |
Novo Nordisk A S
|
9,380 | $449,677 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,465,523 | 218,394 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $54,151,770 | 221,534 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $46,704,475 | 225,680 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $42,100,723 | 227,056 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $35,064,831 | 229,557 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $40,051,686 | 241,508 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $35,026,963 | 242,200 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $39,700,161 | 244,972 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $36,102,981 | 247,010 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 | $39,477,579 | 249,558 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $40,164,938 | 256,252 | Shares | Defined | 2024-02-01 | |
| 2023-09-30 | $41,893,478 | 268,979 | Shares | Defined | 2023-10-27 | |
| 2023-06-30 | $44,336,020 | 267,859 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $42,064,055 | 271,381 | Shares | Defined | 2023-04-28 | |
| 2022-12-31 | $48,755,046 | 275,998 | Shares | Defined | 2023-02-02 | |
| 2022-09-30 | $45,919,352 | 281,093 | Shares | Defined | 2022-10-28 | |
| 2022-06-30 | $49,496,887 | 278,840 | Shares | Defined | 2022-08-01 | |
| 2022-03-31 | $49,662,149 | 280,213 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $48,470,801 | 283,339 | Shares | Defined | 2022-01-31 | |
| 2021-09-30 | $47,771,699 | 295,800 | Shares | Defined | 2021-10-26 | |
| 2021-06-30 | $49,936,647 | 303,124 | Shares | Defined | 2021-07-26 | |
| 2021-03-31 | $50,307,370 | 306,099 | Shares | Defined | 2021-04-29 | |
| 2020-12-31 | $68,428,351 | 434,797 | Shares | Defined | 2021-02-02 | |
| 2020-09-30 | $89,400,057 | 600,484 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $85,431,740 | 607,493 | Shares | Defined | 2020-08-03 | |
| 2020-03-31 | $79,902,622 | 609,339 | Shares | Defined | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||